Search Videos and More
What’s New in GI 2024
What’s New in GI will provide attendees with practical information that can be applied today in their clinical practice. Discussions will include the latest updates on recognizing symptoms and using current data to establish diagnoses and formulate appropriate treatment plans for the management of gastrointestinal diseases. Several topics will be presented at this one-day symposium through lectures and Q&A session for UT Southwestern experts in the field of gastroenterology. This course is designed for gastroenterologists, GI surgeons, internal medicine physicians, family practice physicians, nurse practitioners, physician assistants and other health care providers with an interest in gastroenterology.Gut microbiome offers clues to disparities in rectal cancer
UT Southwestern study identifies clustering of specific gut bacteria associated with race, ethnicity in patientsEthnic minorities face higher risk of liver transplant failure
UTSW study of patients with alcohol-associated diseases could lead to interventions that improve outcomes of these proceduresHow an experimental drug reverses fatty liver disease
Promising treatment in clinical trials has double action against triglyceride and fatty acid synthesis, UTSW study showsInside the OR: Robotic Pancreatic Surgery
The Whipple procedure is one of the most technically challenging abdominal surgeries – and it is also a UT Southwestern specialty. In this video, Dr. Herbert Zeh, Chair of our Department of Surgery, and Dr. Patricio Polanco, a GI and robotic surgery expert, take you inside the operating room for a firsthand look at this complex surgery.Personalized approach suggested on colorectal cancer screening
Conventional age-based guidelines for screening do not account for health status, life expectancy, UT Southwestern researchers findUTSW researcher receives NIH Director’s New Innovator Award
Funding will spur gastroenterologist’s investigation into how tumor location affects outcomes in cancer casesUTSW researchers identify driver of inflammatory bowel disease
Researchers at UT Southwestern Medical Center have discovered an intracellular mechanism that converts protective intestinal cells into disease-driving pathogenic cells, a finding that could lead to improved treatments for patients with inflammatory bowel disease (IBD).Tumor loss-of-function mutations in STK11/LKB1 induce cachexia
Cancer cachexia (CC), a wasting syndrome of muscle and adipose tissue resulting in weight loss, is observed in 50% of patients with solid tumors. Management of CC is limited by the absence of biomarkers and knowledge of molecules that drive its phenotype.UT Southwestern: A global leader in robotic pancreas surgery
Traditionally performed through a large incision, at UT Southwestern our pancreatic cancer surgeons have specialized in robotic-assisted Whipple surgery, a more precise approach through smaller incisions that has been proven to benefit patients with faster recovery times, less pain, less use of pain medication, and prompter return to work. It has also been shown to have comparable cancer treatment results with lower rates of complications and transfusions than the open surgery.UT Southwestern scientists discover agent that reverses effects of intoxication
A shot of a liver-produced hormone called FGF21 sobered up mice that had passed out from alcohol, allowing them to regain consciousness and coordination much faster than those that didn’t receive this treatment, UT Southwestern researchers report in a new study.Inflammation Linked to Insulin Resistance and Fatty Liver Disease
UT Southwestern researchers demonstrate that in obesity, activation of antiviral pathways link inflammation to nonalcoholic fatty liver disease (NAFLD) and dysglycemia.